Published in J Cardiovasc Electrophysiol on February 01, 2010
Current hot potatoes in atrial fibrillation ablation. Curr Cardiol Rev (2012) 0.93
Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system. Circ Arrhythm Electrophysiol (2012) 0.88
Contribution of fibrosis and the autonomic nervous system to atrial fibrillation electrograms in heart failure. Circ Arrhythm Electrophysiol (2012) 0.82
Is Mapping of Complex Fractionated Electrograms Obsolete? Arrhythm Electrophysiol Rev (2015) 0.77
The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol (2015) 0.76
CFAE: "I know it when I see it!" But what does it mean? J Cardiovasc Electrophysiol (2011) 0.75
A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol (2004) 7.26
Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol (1966) 3.77
Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation (2000) 3.43
Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation (1998) 2.99
Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation (2007) 2.87
Technique and results of linear ablation at the mitral isthmus. Circulation (2004) 2.74
Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol (2006) 2.57
Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol (2008) 2.50
Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation (2006) 2.47
Mechanisms of wave fractionation at boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep heart during atrial fibrillation. Circulation (2006) 2.30
Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation (1997) 2.29
High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm (2006) 2.10
Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J (1994) 2.06
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation (2001) 1.78
The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res (1970) 1.77
Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation (2000) 1.74
Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol (2009) 1.74
Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol (2005) 1.66
Complex fractionated electrogram distribution and temporal stability in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 1.63
Unique autonomic profile of the pulmonary veins and posterior left atrium. J Am Coll Cardiol (2007) 1.56
Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium. Circ Res (1992) 1.49
Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol (2007) 1.30
Studies on the mechanism of sinus node dysfunction in the sick sinus syndrome. Circulation (1978) 1.26
Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm (2006) 1.18
Autonomic mechanism for complex fractionated atrial electrograms: evidence by fast fourier transform analysis. J Cardiovasc Electrophysiol (2008) 1.06
High-density mapping of atrial fibrillation in humans: relationship between high-frequency activation and electrogram fractionation. J Cardiovasc Electrophysiol (2008) 1.03
Electrophysiologic characteristics of complex fractionated atrial electrograms in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.93
Atrial fibrillatory cycle length: computer simulation and potential clinical importance. Europace (2007) 0.93
Spatial and temporal stability of complex fractionated electrograms in patients with persistent atrial fibrillation over longer time periods: relationship to local electrogram cycle length. Heart Rhythm (2008) 0.92
Spatial distribution and frequency dependence of arrhythmogenic vagal effects in canine atria. J Cardiovasc Electrophysiol (2000) 0.81
Acetylcholinesterase changes in hearts with sinus rhythm and atrial fibrillation. Gen Pharmacol (1993) 0.81
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med (2002) 4.89
Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation (2005) 4.75
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation (2008) 4.43
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12
Mapping and ablation of idiopathic ventricular fibrillation. Circulation (2002) 3.69
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol (2012) 3.56
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol (2011) 3.00
The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm (2012) 2.87
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation (2012) 2.80
Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol (2010) 2.75
Technique and results of linear ablation at the mitral isthmus. Circulation (2004) 2.74
Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol (2004) 2.63
Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation (2004) 2.63
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation (2003) 2.56
Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation (2004) 2.50
Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol (2008) 2.50
Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc Electrophysiol (2002) 2.36
Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol (2007) 2.25
The future of fellowship training in clinical cardiac electrophysiology: Program directors' perspective 2008. Heart Rhythm (2009) 2.22
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol (2011) 2.21
Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm (2010) 2.19
Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation. Europace (2013) 2.14
Management of atrial fibrillation in chronic kidney disease: double trouble. Am Heart J (2013) 2.14
Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins. Eur Heart J (2005) 2.14
Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J Am Coll Cardiol (2009) 2.12
High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm (2006) 2.10
Can we still rely on the ECG for detecting past myocardial injury? JACC Cardiovasc Imaging (2013) 2.02
"Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol (2004) 2.00
[Senile systemic amyloidosis: definition, diagnosis, why thinking about?]. Presse Med (2013) 2.00
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98